nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—Lucanthone—TOP2A—adrenal gland cancer	0.051	0.541	CrCbGaD
Procainamide—SCN7A—cardiac atrium—adrenal gland cancer	0.0207	0.0604	CbGeAlD
Procainamide—DNMT1—adrenal cortex—adrenal gland cancer	0.0192	0.0561	CbGeAlD
Procainamide—CYP2D6—urine—adrenal gland cancer	0.0192	0.056	CbGeAlD
Procainamide—SCN7A—adrenal gland—adrenal gland cancer	0.0181	0.0527	CbGeAlD
Procainamide—Lidocaine—EGFR—adrenal gland cancer	0.0169	0.18	CrCbGaD
Procainamide—DNMT1—gonad—adrenal gland cancer	0.0159	0.0465	CbGeAlD
Procainamide—DNMT1—cardiac atrium—adrenal gland cancer	0.0159	0.0464	CbGeAlD
Procainamide—SCN9A—pituitary gland—adrenal gland cancer	0.0158	0.0462	CbGeAlD
Procainamide—DNMT1—pituitary gland—adrenal gland cancer	0.0155	0.0453	CbGeAlD
Procainamide—SCN9A—adrenal gland—adrenal gland cancer	0.0141	0.0413	CbGeAlD
Procainamide—SCN4A—pituitary gland—adrenal gland cancer	0.0141	0.0412	CbGeAlD
Procainamide—DNMT1—adrenal gland—adrenal gland cancer	0.0139	0.0405	CbGeAlD
Procainamide—SCN4A—adrenal gland—adrenal gland cancer	0.0126	0.0368	CbGeAlD
Procainamide—SCN2A—pituitary gland—adrenal gland cancer	0.0125	0.0365	CbGeAlD
Procainamide—SCN10A—pituitary gland—adrenal gland cancer	0.012	0.0352	CbGeAlD
Procainamide—ACHE—adrenal gland—adrenal gland cancer	0.0113	0.0329	CbGeAlD
Procainamide—SCN5A—cardiac atrium—adrenal gland cancer	0.0112	0.0327	CbGeAlD
Procainamide—SCN3A—pituitary gland—adrenal gland cancer	0.011	0.0321	CbGeAlD
Procainamide—SCN3A—adrenal gland—adrenal gland cancer	0.00981	0.0287	CbGeAlD
Procainamide—SLC22A4—pituitary gland—adrenal gland cancer	0.00962	0.0281	CbGeAlD
Procainamide—SLC22A3—gonad—adrenal gland cancer	0.00897	0.0262	CbGeAlD
Procainamide—SLC22A4—adrenal gland—adrenal gland cancer	0.00859	0.0251	CbGeAlD
Procainamide—SLC22A5—adrenal cortex—adrenal gland cancer	0.00788	0.023	CbGeAlD
Procainamide—SLC22A3—adrenal gland—adrenal gland cancer	0.00782	0.0228	CbGeAlD
Procainamide—SLC22A5—cardiac atrium—adrenal gland cancer	0.00651	0.019	CbGeAlD
Procainamide—SLC22A5—pituitary gland—adrenal gland cancer	0.00636	0.0186	CbGeAlD
Procainamide—BCHE—cardiac atrium—adrenal gland cancer	0.00634	0.0185	CbGeAlD
Procainamide—Benzocaine—ABCB1—adrenal gland cancer	0.00632	0.067	CrCbGaD
Procainamide—BCHE—pituitary gland—adrenal gland cancer	0.0062	0.0181	CbGeAlD
Procainamide—SLC22A5—adrenal gland—adrenal gland cancer	0.00568	0.0166	CbGeAlD
Procainamide—BCHE—adrenal gland—adrenal gland cancer	0.00554	0.0162	CbGeAlD
Procainamide—Probenecid—ABCB1—adrenal gland cancer	0.00536	0.0568	CrCbGaD
Procainamide—Aminohippurate—ABCB1—adrenal gland cancer	0.00528	0.056	CrCbGaD
Procainamide—Lidocaine—ABCB1—adrenal gland cancer	0.00515	0.0546	CrCbGaD
Procainamide—Sunitinib—ABCB1—adrenal gland cancer	0.00421	0.0447	CrCbGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.00417	0.0074	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—KCNJ5—adrenal gland cancer	0.00406	0.00721	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00394	0.00699	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.00387	0.00688	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—MED12—adrenal gland cancer	0.00386	0.00685	CbGpPWpGaD
Procainamide—SCN7A—Axon guidance—CDC42—adrenal gland cancer	0.00376	0.00667	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—KCNJ5—adrenal gland cancer	0.00362	0.00643	CbGpPWpGaD
Procainamide—SCN7A—L1CAM interactions—EGFR—adrenal gland cancer	0.00361	0.00642	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—MED12—adrenal gland cancer	0.00353	0.00627	CbGpPWpGaD
Procainamide—SCN11A—Axon guidance—CDC42—adrenal gland cancer	0.00335	0.00594	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00326	0.00579	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—KCNJ5—adrenal gland cancer	0.00324	0.00574	CbGpPWpGaD
Procainamide—SCN11A—L1CAM interactions—EGFR—adrenal gland cancer	0.00322	0.00572	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—CDC42—adrenal gland cancer	0.00306	0.00543	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—KCNJ5—adrenal gland cancer	0.00302	0.00535	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—NR5A1—adrenal gland cancer	0.00296	0.00525	CbGpPWpGaD
Procainamide—SCN8A—L1CAM interactions—EGFR—adrenal gland cancer	0.00295	0.00523	CbGpPWpGaD
Procainamide—ACHE—ATF-2 transcription factor network—RB1—adrenal gland cancer	0.00286	0.00507	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—MED12—adrenal gland cancer	0.00286	0.00507	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—NR5A1—adrenal gland cancer	0.00279	0.00496	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—MED12—adrenal gland cancer	0.00273	0.00485	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—CDC42—adrenal gland cancer	0.00268	0.00476	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—MED12—adrenal gland cancer	0.00262	0.00466	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—MED12—adrenal gland cancer	0.00262	0.00466	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—MED12—adrenal gland cancer	0.00253	0.00449	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—MED12—adrenal gland cancer	0.00253	0.00449	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00252	0.00447	CbGpPWpGaD
Procainamide—DNMT1—Retinoblastoma (RB) in Cancer—TP53—adrenal gland cancer	0.00249	0.00442	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—CDC42—adrenal gland cancer	0.00248	0.0044	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.00239	0.00425	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—CDC42—adrenal gland cancer	0.00239	0.00424	CbGpPWpGaD
Procainamide—SCN9A—L1CAM interactions—EGFR—adrenal gland cancer	0.00238	0.00423	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—CDC42—adrenal gland cancer	0.00237	0.0042	CbGpPWpGaD
Procainamide—SCN3A—L1CAM interactions—EGFR—adrenal gland cancer	0.00228	0.00405	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—CDC42—adrenal gland cancer	0.00228	0.00404	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—CDC42—adrenal gland cancer	0.00228	0.00404	CbGpPWpGaD
Procainamide—ACHE—Peptide hormone metabolism—POMC—adrenal gland cancer	0.0022	0.0039	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—CDC42—adrenal gland cancer	0.00219	0.00389	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—CDC42—adrenal gland cancer	0.00219	0.00389	CbGpPWpGaD
Procainamide—SCN2A—L1CAM interactions—EGFR—adrenal gland cancer	0.00219	0.00389	CbGpPWpGaD
Procainamide—SCN4A—L1CAM interactions—EGFR—adrenal gland cancer	0.00219	0.00389	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—CDC42—adrenal gland cancer	0.00218	0.00388	CbGpPWpGaD
Procainamide—SCN10A—L1CAM interactions—EGFR—adrenal gland cancer	0.00211	0.00375	CbGpPWpGaD
Procainamide—SCN1A—L1CAM interactions—EGFR—adrenal gland cancer	0.00211	0.00375	CbGpPWpGaD
Procainamide—ACHE—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00203	0.00361	CbGpPWpGaD
Procainamide—BCHE—Peptide hormone metabolism—POMC—adrenal gland cancer	0.00196	0.00348	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00192	0.0034	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00181	0.00322	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—MED12—adrenal gland cancer	0.00178	0.00316	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—CDC42—adrenal gland cancer	0.00177	0.00314	CbGpPWpGaD
Procainamide—CHRM2—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00175	0.0031	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—CDC42—adrenal gland cancer	0.00169	0.003	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00168	0.00299	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—MED12—adrenal gland cancer	0.00168	0.00298	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.00168	0.00297	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—CDC42—adrenal gland cancer	0.00162	0.00288	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—CDC42—adrenal gland cancer	0.00162	0.00288	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00162	0.00287	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—MEN1—adrenal gland cancer	0.0016	0.00285	CbGpPWpGaD
Procainamide—ACHE—Peptide hormone metabolism—CTNNB1—adrenal gland cancer	0.00157	0.00278	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—CDC42—adrenal gland cancer	0.00157	0.00278	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—CDC42—adrenal gland cancer	0.00157	0.00278	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—PRKACA—adrenal gland cancer	0.00156	0.00276	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—CDC42—adrenal gland cancer	0.00154	0.00274	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00151	0.00268	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00151	0.00268	CbGpPWpGaD
Procainamide—SCN5A—L1CAM interactions—EGFR—adrenal gland cancer	0.00148	0.00264	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00148	0.00263	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—SDHB—adrenal gland cancer	0.00142	0.00252	CbGpPWpGaD
Procainamide—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00142	0.00251	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00141	0.0025	CbGpPWpGaD
Procainamide—BCHE—Peptide hormone metabolism—CTNNB1—adrenal gland cancer	0.0014	0.00248	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—PRKACA—adrenal gland cancer	0.00139	0.00246	CbGpPWpGaD
Procainamide—SCN7A—Axon guidance—EGFR—adrenal gland cancer	0.00137	0.00243	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00134	0.00238	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00127	0.00226	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.00125	0.00221	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—REN—adrenal gland cancer	0.00125	0.00221	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—PRKACA—adrenal gland cancer	0.00124	0.0022	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—CTNNB1—adrenal gland cancer	0.00123	0.00218	CbGpPWpGaD
Procainamide—SCN11A—Axon guidance—EGFR—adrenal gland cancer	0.00122	0.00216	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00121	0.00214	CbGpPWpGaD
Procainamide—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00119	0.00211	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—PRKACA—adrenal gland cancer	0.00116	0.00205	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00115	0.00204	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00114	0.00203	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00112	0.00199	CbGpPWpGaD
Procainamide—ACHE—Metabolism—SDHB—adrenal gland cancer	0.00112	0.00198	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—EGFR—adrenal gland cancer	0.00111	0.00198	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—REN—adrenal gland cancer	0.00111	0.00197	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—CDC42—adrenal gland cancer	0.0011	0.00195	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—CTNNB1—adrenal gland cancer	0.0011	0.00195	CbGpPWpGaD
Procainamide—ACHE—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00109	0.00194	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00108	0.00192	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00108	0.00191	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00106	0.00189	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00106	0.00188	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00102	0.00182	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—CTNNB1—adrenal gland cancer	0.001	0.00178	CbGpPWpGaD
Procainamide—BCHE—Metabolism—SDHB—adrenal gland cancer	0.000997	0.00177	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000983	0.00175	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.000983	0.00174	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.000976	0.00173	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—EGFR—adrenal gland cancer	0.000975	0.00173	CbGpPWpGaD
Procainamide—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000966	0.00171	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.000941	0.00167	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.000917	0.00163	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—SDHD—adrenal gland cancer	0.000915	0.00162	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—RRM1—adrenal gland cancer	0.000915	0.00162	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—EGFR—adrenal gland cancer	0.000901	0.0016	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—SDHB—adrenal gland cancer	0.000891	0.00158	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00088	0.00156	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.000872	0.00155	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—EGFR—adrenal gland cancer	0.000869	0.00154	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—EGFR—adrenal gland cancer	0.000861	0.00153	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000861	0.00153	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000859	0.00152	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000845	0.0015	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000842	0.0015	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—BRAF—adrenal gland cancer	0.000839	0.00149	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—SDHB—adrenal gland cancer	0.00083	0.00147	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—EGFR—adrenal gland cancer	0.000828	0.00147	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—EGFR—adrenal gland cancer	0.000828	0.00147	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000821	0.00146	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.000813	0.00144	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—CTNNB1—adrenal gland cancer	0.000811	0.00144	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—EGFR—adrenal gland cancer	0.000798	0.00142	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—EGFR—adrenal gland cancer	0.000798	0.00142	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—EGFR—adrenal gland cancer	0.000795	0.00141	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000785	0.00139	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—CTNNB1—adrenal gland cancer	0.000776	0.00138	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—BRAF—adrenal gland cancer	0.000748	0.00133	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—CTNNB1—adrenal gland cancer	0.000745	0.00132	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—CTNNB1—adrenal gland cancer	0.000745	0.00132	CbGpPWpGaD
Procainamide—ACHE—Metabolism—RRM1—adrenal gland cancer	0.00072	0.00128	CbGpPWpGaD
Procainamide—ACHE—Metabolism—SDHD—adrenal gland cancer	0.00072	0.00128	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—CTNNB1—adrenal gland cancer	0.000719	0.00128	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—CTNNB1—adrenal gland cancer	0.000719	0.00128	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—MED12—adrenal gland cancer	0.000682	0.00121	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—BRAF—adrenal gland cancer	0.000668	0.00119	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000667	0.00118	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.000662	0.00117	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000655	0.00116	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.00065	0.00115	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000649	0.00115	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—EGFR—adrenal gland cancer	0.000643	0.00114	CbGpPWpGaD
Procainamide—BCHE—Metabolism—RRM1—adrenal gland cancer	0.000643	0.00114	CbGpPWpGaD
Procainamide—BCHE—Metabolism—SDHD—adrenal gland cancer	0.000643	0.00114	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—BRAF—adrenal gland cancer	0.000623	0.00111	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—IGF2—adrenal gland cancer	0.000622	0.0011	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000621	0.0011	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—EGFR—adrenal gland cancer	0.000615	0.00109	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—GNAS—adrenal gland cancer	0.000595	0.00106	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—EGFR—adrenal gland cancer	0.000591	0.00105	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—EGFR—adrenal gland cancer	0.000591	0.00105	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000589	0.00105	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GNRHR—adrenal gland cancer	0.000581	0.00103	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000578	0.00103	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—SDHD—adrenal gland cancer	0.000574	0.00102	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—RRM1—adrenal gland cancer	0.000574	0.00102	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—EGFR—adrenal gland cancer	0.00057	0.00101	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—EGFR—adrenal gland cancer	0.00057	0.00101	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—EGFR—adrenal gland cancer	0.000561	0.000996	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—IGF2—adrenal gland cancer	0.000555	0.000984	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.000546	0.000969	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00054	0.000959	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00054	0.000959	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.000539	0.000956	CbGpPWpGaD
Procainamide—ACHE—Metabolism—MED12—adrenal gland cancer	0.000537	0.000954	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—SDHD—adrenal gland cancer	0.000535	0.00095	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—RRM1—adrenal gland cancer	0.000535	0.00095	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00053	0.000941	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000526	0.000934	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—TSHR—adrenal gland cancer	0.000525	0.000932	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	0.000513	0.00091	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000508	0.000901	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—CTNNB1—adrenal gland cancer	0.000505	0.000897	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000504	0.000894	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PRKACA—adrenal gland cancer	0.000498	0.000884	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000494	0.000877	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.00048	0.000852	CbGpPWpGaD
Procainamide—BCHE—Metabolism—MED12—adrenal gland cancer	0.000479	0.000851	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SDHB—adrenal gland cancer	0.000459	0.000814	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000428	0.00076	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—MED12—adrenal gland cancer	0.000428	0.00076	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—POMC—adrenal gland cancer	0.000415	0.000737	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GNAS—adrenal gland cancer	0.000403	0.000716	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—POMC—adrenal gland cancer	0.000401	0.000711	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—EGFR—adrenal gland cancer	0.0004	0.000711	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—MED12—adrenal gland cancer	0.000399	0.000708	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ABCB1—adrenal gland cancer	0.000396	0.000703	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PRKACA—adrenal gland cancer	0.000392	0.000696	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000383	0.00068	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000377	0.000669	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—POMC—adrenal gland cancer	0.00037	0.000657	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000352	0.000625	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PRKACA—adrenal gland cancer	0.00035	0.000621	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GNRH1—adrenal gland cancer	0.000348	0.000618	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000342	0.000607	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000336	0.000597	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CDC42—adrenal gland cancer	0.00032	0.000567	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000318	0.000565	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GNAS—adrenal gland cancer	0.000318	0.000564	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PRKACA—adrenal gland cancer	0.000312	0.000554	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ABCB1—adrenal gland cancer	0.000312	0.000553	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TSHR—adrenal gland cancer	0.00031	0.000551	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000305	0.000542	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—CTNNB1—adrenal gland cancer	0.000296	0.000526	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.000295	0.000525	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.000295	0.000525	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MEN1—adrenal gland cancer	0.000292	0.000518	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PRKACA—adrenal gland cancer	0.000291	0.000517	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GNAS—adrenal gland cancer	0.000283	0.000503	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ABCB1—adrenal gland cancer	0.000278	0.000494	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—POMC—adrenal gland cancer	0.000272	0.000482	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—CTNNB1—adrenal gland cancer	0.000264	0.000469	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GNAS—adrenal gland cancer	0.000253	0.000449	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ABCB1—adrenal gland cancer	0.000248	0.000441	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GNAS—adrenal gland cancer	0.000236	0.000419	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ABCB1—adrenal gland cancer	0.000231	0.000411	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000226	0.000402	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000223	0.000395	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.00022	0.000391	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PTGS2—adrenal gland cancer	0.000217	0.000385	CbGpPWpGaD
Procainamide—ACHE—Metabolism—POMC—adrenal gland cancer	0.000214	0.00038	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	0.000206	0.000365	CbGpPWpGaD
Procainamide—BCHE—Metabolism—POMC—adrenal gland cancer	0.000191	0.000339	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	0.000189	0.000335	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	0.000182	0.000323	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	0.00018	0.00032	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000176	0.000312	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PTGS2—adrenal gland cancer	0.000171	0.000303	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—POMC—adrenal gland cancer	0.00017	0.000302	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	0.000161	0.000285	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—POMC—adrenal gland cancer	0.000159	0.000282	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PTGS2—adrenal gland cancer	0.000152	0.00027	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	0.000151	0.000269	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PTGS2—adrenal gland cancer	0.000136	0.000241	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	0.000132	0.000234	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GNAS—adrenal gland cancer	0.00013	0.000231	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	0.000128	0.000227	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PTGS2—adrenal gland cancer	0.000127	0.000225	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	0.000121	0.000216	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	0.00012	0.000213	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000116	0.000206	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—POMC—adrenal gland cancer	8.77e-05	0.000156	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	8.67e-05	0.000154	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	7e-05	0.000124	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	6.87e-05	0.000122	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	5.77e-05	0.000102	CbGpPWpGaD
